Does VALBENAZINE Cause Salivary hypersecretion? 134 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 134 reports of Salivary hypersecretion have been filed in association with VALBENAZINE (INGREZZA). This represents 0.6% of all adverse event reports for VALBENAZINE.
134
Reports of Salivary hypersecretion with VALBENAZINE
0.6%
of all VALBENAZINE reports
1
Deaths
4
Hospitalizations
How Dangerous Is Salivary hypersecretion From VALBENAZINE?
Of the 134 reports, 1 (0.7%) resulted in death, 4 (3.0%) required hospitalization.
Is Salivary hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALBENAZINE. However, 134 reports have been filed with the FAERS database.
What Other Side Effects Does VALBENAZINE Cause?
Drug ineffective (2,625)
Somnolence (2,339)
Fatigue (1,599)
Tremor (1,455)
Tardive dyskinesia (1,383)
Fall (1,056)
Dizziness (887)
Death (879)
Therapeutic product effect decreased (823)
Drooling (821)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
Which VALBENAZINE Alternatives Have Lower Salivary hypersecretion Risk?
VALBENAZINE vs VALBENAZINE DITOSYLATE
VALBENAZINE vs VALDECOXIB
VALBENAZINE vs VALERIAN
VALBENAZINE vs VALGANCICLOVIR
VALBENAZINE vs VALIUM